Interleukin 25 in allergic airway inflammation

Area of Science:

• Immunology
• Allergy Research
• Respiratory Medicine

Background:

• T helper 2 (Th2) cells drive allergic inflammation via cytokines like IL-4, IL-5, and IL-13.
• A novel IL-17 family cytokine, IL-25 (IL-17E), is produced by activated Th2 cells and mast cells.
• Systemic IL-25 administration in mice induces Th2 immune responses, including eosinophilia and elevated IgE.

Purpose of the Study:

• To investigate the role of IL-25 in allergic airway inflammation.
• To determine the mechanism by which IL-25 influences Th2-type immune responses in the airways.

Main Methods:

• Analysis of IL-25 mRNA expression in mouse lungs following inhaled antigen challenge.
• Administration of soluble IL-25 receptor to neutralize IL-25.
• Enforced IL-25 expression in the lung.
• Depletion of CD4+ T cells to assess their role.

Main Results:

• IL-25 mRNA is upregulated in the lung after antigen challenge in sensitized mice.
• Neutralization of IL-25 reduces antigen-induced eosinophil and CD4+ T cell recruitment to the airways.
• Enforced IL-25 expression enhances antigen-induced Th2 cytokine production and eosinophil recruitment.
• IL-25-mediated enhancement of eosinophil recruitment is dependent on CD4+ T cells.

Conclusions:

• IL-25 plays a significant role in promoting allergic airway inflammation.
• The pro-inflammatory effects of IL-25 in the airways are mediated through a CD4+ T-cell-dependent mechanism.